Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine

Clinical trial NCT01447407 · COMPLETED

Trial details

NCT number: NCT01447407
Sponsor: NovaDigm Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Staphylococcal Infections Yeast Infections Candidiasis

Start date: 2011-09-01
Primary completion: 2012-03-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.